Cargando…
Erratum: Drug-Targeted Inhibition of Peroxisome Proliferator-Activated Receptor-gamma Enhances the Chemopreventive Effect of Anti-Estrogen Therapy
Autores principales: | Yuan, Hongyan, Kopelovich, Levy, Yin, Yuzhi, Lu, Jin, Glazer, Robert I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173472/ https://www.ncbi.nlm.nih.gov/pubmed/30333917 http://dx.doi.org/10.18632/oncotarget.26161 |
Ejemplares similares
-
Drug-Targeted Inhibition of Peroxisome Proliferator-Activated Receptorγ Enhances the Chemopreventive Effect of Anti-Estrogen
por: Yuan, Hongyan, et al.
Publicado: (2012) -
Erratum to “Peroxisome Proliferator-Activated Receptors Alpha, Beta, and Gamma mRNA and Protein Expression in Human Fetal Tissues”
por: Abbott, Barbara D., et al.
Publicado: (2010) -
PPARs as determinants of the estrogen receptor lineage: use of synthetic lethality for the treatment of estrogen receptor-negative breast cancer
por: Glazer, Robert I., et al.
Publicado: (2017) -
Induction of Metastatic Gastric Cancer by Peroxisome Proliferator-Activated Receptorδ Activation
por: Pollock, Claire B., et al.
Publicado: (2010) -
Association between peroxisome proliferator-activated receptor-alpha, delta, and gamma polymorphisms and risk of coronary heart disease: A case–control study and meta-analysis: Erratum
Publicado: (2017)